As we look ahead to 2025, a number of factors poise the clinical laboratory market for continued transformation. The post-COVID-19 landscape is reshaping the industry, presenting both challenges and ...
Rocket Lab is on track for 'a similarly aggressive growth trajectory as SpaceX,' writes KeyBanc Capital Markets analyst Michael Leshock Rocket Lab USA Inc.'s stock initially tumbled in the wake of the ...
Today, health plans are shifting dollars to more value-based contracts along with investments in population health management. Digitizing lab results across all care settings and unlocking the ...
Rocket Lab USA Inc.’s stock initially tumbled in the wake of the company’s fourth-quarter results Thursday, weighed down by weak outlook, although an analyst KeyBanc Capital Markets believes the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results